AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Intaglip-M OD 500 Tablet SR

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Metformin (500mg) + Vildagliptin (100mg)

Overview Intaglip-M OD 500 Tablet SR

Combiflex-DM 500mg Extended-Release tablets combine two agents to manage elevated blood glucose in type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Combiflex-DM 500mg ER may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized, based on your health status, glucose readings, and concurrent medications. Consuming it with food minimizes stomach discomfort. Consistent daily dosing, at the same time, maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Effective blood sugar control mitigates future complications. Continued adherence to your prescribed diet and exercise plan is crucial. Lifestyle choices significantly impact diabetes management. Commonly reported side effects include diarrhea, nausea, vomiting, dyspepsia, headache, pharyngitis, asthenia, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; familiarity with its recognition and treatment is essential. This medication isn't appropriate for all individuals. Prior to initiating treatment, inform your physician of any history of kidney, liver, or heart disease, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Drug interactions are possible; disclose all medications to your doctor to ensure safety. Alcohol should be avoided due to its potential to lower blood glucose. Your doctor will monitor your renal function and blood glucose levels throughout therapy.

Primary Ingredients of Intaglip-M OD 500 Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Intaglip-M OD 500 Tablet SR

Managing type 2 diabetes

Major Benefits of Intaglip-M OD 500 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Intaglip-M OD 500 Tablet SR whole; do not chew, crush, or divide it. Administer this medication with food.

Common Side effects of Intaglip-M OD 500 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Intaglip-M OD 500 Tablet SR:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; do not crush, chew, or divide it. The Intaglip-M OD 500 SR tablet should be administered with a meal.

How Intaglip-M OD 500 Tablet SR works:

Extended-release Intaglip-M 500mg tablets (once-daily) contain a dual antidiabetic formulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Intaglip-M OD 500 Tablet SR and alcohol poses a significant safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Intaglip-M 500 mg tablet's safety during pregnancy is uncertain. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Intaglip-M 500 mg tablet (once daily) likely poses a risk to breastfeeding infants. Available data from humans indicates potential transfer to breast milk with consequent harm to the child.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such conditions arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Intaglip-M OD 500 SR tablets cautiously. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverUNSAFE

Extended-release Intaglip-M 500 mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.

What if you forget to take Intaglip-M OD 500 Tablet SR :

Should you forget to take your Intaglip-M OD 500 Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Intaglip-M OD 500 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Treatment

FAQs on Intaglip-M OD 500 Tablet SR

Intaglip-M OD 500 Tablet SR rarely causes hypoglycemia by itself, but low blood sugar can result from inadequate calorie intake while using this medication. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. These symptoms are more pronounced if meals are missed or delayed, alcohol is consumed, excessive exercise occurs, or other antidiabetic medications are taken concurrently. Therefore, regular blood sugar monitoring is crucial. Always keep glucose tablets, honey, or fruit juice readily available.
Intaglip-M OD 500 Tablet SR may cause nausea and vomiting. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Do not take other medications without your doctor's approval.
Intaglip-M OD 500 Tablet SR is contraindicated in patients with allergies to its components or excipients, and should not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Intaglip-M OD 500 SR tablets combine the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and improves insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, enhances insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Intaglip-M OD 500 Tablet SR can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Intaglip-M OD 500 Tablet SR and seek immediate medical attention.
Prolonged use of Intaglip-M OD 500 Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Intaglip-M OD 500 Tablet SR is safe when used as directed by your doctor. However, even with proper dosage, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent side effects to your doctor.
Intaglip-M OD 500 Tablet ...
71
MRP 82
13% off